Which country does aliscon vaccine come from?

AstraZeneca vaccine was formed by the merger of Astra Company in Sweden and Telikan Company in Britain. This company has two headquarters, one in London, England, and the other in Shanghai, China.

As a global biopharmaceutical company driven by innovation, it has about 6 1500 employees worldwide and its business covers more than 0/00 countries in the world. The company has established production bases in 17 countries. AstraZeneca attaches great importance to technology. In order to acquire advanced technology, it invests more than 4 billion dollars in R&D every year.

Due to the huge market in China, AstraZeneca pays special attention to the China market. Headquartered in China, AstraZeneca has more than 10000 employees in China, and its sales in China in 20 18 reached US$ 3.795 billion. The company has invested more than 750 million US dollars in China, and established production bases in Wuxi and Taizhou respectively.

Application and present situation of alikang vaccine;

Oxford-AstraZeneca vaccine is a viral vector vaccine containing CHADOX 1-S. According to research, the effective rate of CHADOX1-S is 63.09%. Because it is easy to preserve, it is more suitable for low-and middle-income countries.

12 European countries completely or partially suspended the application of AstraZeneca vaccine: the Netherlands, Denmark, Norway, Iceland, Bulgaria and Ireland decided to suspend the application of AstraZeneca vaccine; Austria, Italy, Luxembourg, Estonia, Lithuania and Latvia also decided to suspend some batches of AstraZeneca vaccine.

Previously, many countries announced the suspension of AstraZeneca vaccine for fear of the risk of thrombosis after vaccination. However, the European Medicines Agency issued a preliminary investigation result, which determined that the advantages of AstraZeneca vaccine "outweigh the disadvantages", and then Germany and France resumed AstraZeneca vaccination.

Refer to the above content: Baidu Encyclopedia-Oxford-AstraZeneca Vaccine